Fresh Tracks Therapeutics (NASDAQ:FRTX) Stock Price Down 0.5% – Should You Sell?

Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTXGet Free Report) fell 0.5% during trading on Friday . The stock traded as low as $0.94 and last traded at $0.94. 2,402 shares changed hands during trading, a decline of 11% from the average session volume of 2,709 shares. The stock had previously closed at $0.94.

Fresh Tracks Therapeutics Trading Down 0.5%

The company has a market capitalization of $5.58 million, a P/E ratio of -0.66 and a beta of 0.54. The company has a 50 day moving average price of $0.94 and a 200 day moving average price of $0.84.

Fresh Tracks Therapeutics Company Profile

(Get Free Report)

Fresh Tracks Therapeutics, Inc does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc was founded in 2009 and is headquartered in Boulder, Colorado.

See Also

Receive News & Ratings for Fresh Tracks Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresh Tracks Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.